Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247254 (US9447029, 1-7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247250 (US9447029, 1-1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247253 (US9447029, 1-6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247256 (US9447029, 1-15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247257 (US9447029, 1-18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247260 (US9447029, 1-32) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247255 (US9447029, 1-14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247259 (US9447029, 1-29) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 700 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247264 (US9447029, 4-1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent N-type calcium channel subunit alpha-1B (Homo sapiens (Human)) | BDBM247263 (US9447029, 3-3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247267 (US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247271 (US9447029, 2-[2-(3-Hexyloxyphenyl)-ethylamino]-N,N...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247268 (US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-1-(pi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247273 (US9447029, 2-{2-[3-(4,4,4-trifluorobutoxy)phenyl]-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247266 (US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247265 (US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-1-(py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247275 (US9447029, 2-{[2-(3-Butoxyphenyl)-ethyl]-(2-methox...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.40E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247270 (US9447029, 2-[2-(3-Pentyloxyphenyl)-ethylamino]-N,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247272 (US9447029, 2-{2-[3-(4,4,4-trifluorobutoxy)-phenyl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM161090 (US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM161090 (US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM161093 (US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247269 (US9447029, 2-{[2-(3-Butoxyphenyl)-ethyl]-(3-methox...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.30E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247274 (US9447029, 2-[2-(3-Benzyloxyphenyl)-ethylamino]-N,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.06E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247252 (US9447029, 1-3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.39E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247260 (US9447029, 1-32) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.40E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247253 (US9447029, 1-6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.78E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247259 (US9447029, 1-29) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.83E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247250 (US9447029, 1-1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247263 (US9447029, 3-3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247264 (US9447029, 4-1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247261 (US9447029, 2-1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247258 (US9447029, 1-21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247255 (US9447029, 1-14) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247262 (US9447029, 3-2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247251 (US9447029, 1-2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247256 (US9447029, 1-15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 2D6 (Homo sapiens (Human)) | BDBM247257 (US9447029, 1-18) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
NEWRON PHARMACEUTICALS S.P.A. US Patent | Assay Description Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37... | US Patent US9447029 (2016) BindingDB Entry DOI: 10.7270/Q26T0KJZ | |||||||||||
More data for this Ligand-Target Pair |